Acute respiratory distress syndrome in patients with and without diffuse alveolar damage: an autopsy study

Objective To demonstrate that among patients with acute respiratory distress syndrome (ARDS), the presence of diffuse alveolar damage (DAD) at histological examination, as compared to its absence, defines a specific subphenotype. Methods We studied 149 patients who died in our ICU with the clinical...

Full description

Autores:
Lorente, José A.
Cardinal-Fernández, Pablo
Muñoz, Diego
Frutos-Vivar, Fernando
Thille, Arnaud W.
Jaramillo, Carlos
Ballén-Barragán, Aida
Rodríguez, José M.
Peñuelas, Oscar
Ortiz, Guillermo
Blanco, José
Valle Pinheiro, Bruno
Nin, Nicolás
Marin, María del Carmen
Esteban, Andrés
Thompson, Taylor B.
Tipo de recurso:
Article of journal
Fecha de publicación:
2015
Institución:
Universidad El Bosque
Repositorio:
Repositorio U. El Bosque
Idioma:
eng
OAI Identifier:
oai:repositorio.unbosque.edu.co:20.500.12495/3711
Acceso en línea:
http://hdl.handle.net/20.500.12495/3711
https://doi.org//10.1007/s00134-015-4046-0
https://repositorio.unbosque.edu.co
Palabra clave:
Adult respiratory distress syndrome
Diffuse alveolar damage
Subphenotype
Histology
Autopsy
Hyaline membranes
Rights
openAccess
License
Acceso abierto
Description
Summary:Objective To demonstrate that among patients with acute respiratory distress syndrome (ARDS), the presence of diffuse alveolar damage (DAD) at histological examination, as compared to its absence, defines a specific subphenotype. Methods We studied 149 patients who died in our ICU with the clinical diagnosis of ARDS according to the Berlin Definition (BD) and who had autopsy examination. We compared the change over time of different clinical variables in patients with (n = 49) and without (n = 100) DAD. A predictive model for the presence of DAD was developed and validated in an independent cohort of 57 patients with ARDS and postmortem examination (21 of them with DAD). Results Patients with DAD, as compared to patients without DAD, had a lower PaO2/FiO2 ratio and dynamic respiratory system compliance, and a higher SOFA score and INR, and were more likely to die of hypoxemia and less likely to die of shock. In multivariate analysis, variables associated with DAD [odds ratio, 95 % confidence interval (CI)] were PaO2/FiO2 ratio [0.988 (0.981–0.995)], dynamic respiratory system compliance [0.937 (0.892–0.984)] and age [0.972 (0.946–0.999)]. Areas under the ROC curve (95 % CI) for the classification of DAD using the regression model or the BD were, respectively, 0.74 (0.65–0.82) and 0.64 (0.55–0.72) (p = 0.03). In the validation cohort, the areas under the ROC curve for the diagnosis of DAD were 0.73 (0.56–0.90) and 0.67 (0.54–0.81) for the regression model and the BD, respectively. Conclusions The presence of DAD appears to define a specific subphenotype in patients with ARDS. Targeting patients with DAD within the population of patients with the clinical diagnosis of ARDS might be appropriate to find effective therapies for this condition.